CH513907A - Verfahren zur Herstellung neuer Thiazolderivate - Google Patents

Verfahren zur Herstellung neuer Thiazolderivate

Info

Publication number
CH513907A
CH513907A CH434369A CH434369A CH513907A CH 513907 A CH513907 A CH 513907A CH 434369 A CH434369 A CH 434369A CH 434369 A CH434369 A CH 434369A CH 513907 A CH513907 A CH 513907A
Authority
CH
Switzerland
Prior art keywords
production
thiazole derivatives
new thiazole
new
derivatives
Prior art date
Application number
CH434369A
Other languages
German (de)
English (en)
Inventor
Hepworth Walter
Joseph Stacey Gilbert
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to CH806271A priority Critical patent/CH513910A/de
Publication of CH513907A publication Critical patent/CH513907A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CH434369A 1968-03-22 1969-03-21 Verfahren zur Herstellung neuer Thiazolderivate CH513907A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH806271A CH513910A (de) 1968-03-22 1969-03-21 Verfahren zur Herstellung neuer Thiazolderivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB03989/68A GB1192701A (en) 1968-03-22 1968-03-22 Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same

Publications (1)

Publication Number Publication Date
CH513907A true CH513907A (de) 1971-10-15

Family

ID=10033003

Family Applications (2)

Application Number Title Priority Date Filing Date
CH434369A CH513907A (de) 1968-03-22 1969-03-21 Verfahren zur Herstellung neuer Thiazolderivate
CH806371A CH553209A (de) 1968-03-22 1969-03-21 Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH806371A CH553209A (de) 1968-03-22 1969-03-21 Verfahren zur herstellung neuer (alpha)-thiazolyl-(alpha)-alkylmalonsaeureester.

Country Status (15)

Country Link
US (1) US3661920A (pt)
AT (1) AT284841B (pt)
BE (1) BE730284A (pt)
BR (1) BR6807374D0 (pt)
CA (1) CA948199A (pt)
CH (2) CH513907A (pt)
CS (3) CS154266B2 (pt)
DE (1) DE1913472A1 (pt)
DK (3) DK125251B (pt)
ES (1) ES365089A1 (pt)
FR (1) FR2004544A1 (pt)
GB (1) GB1192701A (pt)
IE (1) IE32967B1 (pt)
IL (1) IL31679A (pt)
NL (1) NL6903963A (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703542C2 (de) * 1977-01-26 1985-09-26 Schering AG, 1000 Berlin und 4709 Bergkamen Thiazolylzimtsäurenitrile, Insektenbekämpfungsmittel enthaltend diese Verbindungen sowie Verfahren zu ihrer Herstellung
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
US4197306A (en) * 1977-06-30 1980-04-08 Uniroyal, Inc. Aryl-substituted thiazoles
DE2801794A1 (de) 1978-01-17 1979-07-19 Basf Ag Verfahren zur herstellung von thiazolderivaten und neue thiazole
DE2920183A1 (de) * 1979-05-17 1981-04-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Thiazolyliden-oxo-propionitrile, insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
US4346094A (en) * 1980-09-22 1982-08-24 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
US5077305A (en) * 1990-02-13 1991-12-31 Bristol-Myers Squibb Co. Thiazole carboxylic acids and esters
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
DE10331675A1 (de) * 2003-07-14 2005-02-10 Bayer Cropscience Ag Hetarylsubstituierte Pyrazolidindion-Derivate
WO2009052454A2 (en) * 2007-10-19 2009-04-23 University Of California Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss

Also Published As

Publication number Publication date
NL6903963A (pt) 1969-09-24
BE730284A (pt) 1969-09-22
ES365089A1 (es) 1971-01-01
CA948199A (en) 1974-05-28
IE32967L (en) 1969-09-22
CH553209A (de) 1974-08-30
DE1913472A1 (de) 1969-11-06
CS154268B2 (pt) 1974-03-29
DK125251B (da) 1973-01-22
US3661920A (en) 1972-05-09
GB1192701A (en) 1970-05-20
AT284841B (de) 1970-09-25
BR6807374D0 (pt) 1973-02-08
DK125326B (da) 1973-02-05
IL31679A (en) 1972-08-30
CS154267B2 (pt) 1974-03-29
DK122393B (da) 1972-02-28
IE32967B1 (en) 1974-02-06
FR2004544A1 (pt) 1969-11-28
CS154266B2 (pt) 1974-03-29

Similar Documents

Publication Publication Date Title
AT326674B (de) Verfahren zur herstellung neuer naphthyridinderivaten
AT292695B (de) Verfahren zur Herstellung neuer Isoxazolderivate
CH529763A (de) Verfahren zur Herstellung neuer Hexahydrobenzazocine
CH513907A (de) Verfahren zur Herstellung neuer Thiazolderivate
CH504426A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
CH535730A (de) Verfahren zur Herstellung neuer Naphthylalkanole
AT303272B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
CH517684A (de) Verfahren zur Herstellung neuer Prostaglandinderivate
CH517728A (de) Verfahren zur Herstellung neuer basisch substituierter Cumarinderivate
CH446340A (de) Verfahren zur Herstellung neuer Phenthiazinderivate
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
CH498817A (de) Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine
AT307632B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate
CH537370A (de) Verfahren zur Herstellung neuer Guanidin-Derivate
AT299941B (de) Verfahren zur Herstellung neuer Thiazolderivate
CH497402A (de) Verfahren zur Herstellung neuer Isothiocyanato-N-alkanoyl-diphenylamine
CH520703A (de) Verfahren zur Herstellung neuer Thiazol-Derivate
CH511789A (de) Verfahren zur Herstellung neuer Dichlor-trifluormethylbenzoesäuren
CH511227A (de) Verfahren zur Herstellung neuer Azetidinolderivate
CH497401A (de) Verfahren zur Herstellung neuer Isothiocyanato-N-nitroso-diphenylamine
CH520698A (de) Verfahren zur Herstellung neuer Piperazinoindole
CH536297A (de) Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane
AT310163B (de) Verfahren zur Herstellung neuer Oxazol- bzw. Thiazol-Derivate

Legal Events

Date Code Title Description
PL Patent ceased